Save your screen. Keep the bounds you have set, and get an email when an insider trades at a company it holds. A free account does both.
| Stock | FY | Clue Score ↑ | Market cap ↓ | Stock price ↓ | % change ↓ | PE ratio ↓ | Return on invested capital ↓ | Revenue growth 3Y ↓ | Net margin ↓ | Insider buyers 12M ↓ | Debt to equity ↓ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERAVera Therapeutics, Inc. | 2025 | 36 | $2.00B | $27.72 | -7.23% | — | -36.69% | — | — | 1 | 0.12 |